ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,341Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 199

$1.38M Total Retail Price of All Prescriptions

Rank: 3 out of 199

979 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 979 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 979 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 904 791 152 1 1
ATORVASTATIN CALCIUM 675 618 125 2 8
AMLODIPINE BESYLATE 641 596 125 3 3
OMEPRAZOLE 575 538 99 4 4
WARFARIN SODIUM 541 515 76 5 7
PRAVASTATIN SODIUM 532 466 108 6 18
SIMVASTATIN 517 480 104 7 2
PREDNISONE 475 393 105 8 33
LOSARTAN POTASSIUM 437 409 87 9 15
TRAMADOL HCL 429 377 112 10 16
CRESTOR 427 379 74 11 31
FUROSEMIDE 425 396 90 12 5
LISINOPRIL 418 383 80 13 6
METOPROLOL TARTRATE 362 333 70 14 12
SERTRALINE HCL 359 339 69 15 23
METOPROLOL SUCCINATE 352 340 61 16 11
ALLOPURINOL 342 316 63 17 22
POTASSIUM CHLORIDE 324 273 64 18 10
ALPRAZOLAM 310 237 61 B 19 24
BUMETANIDE 298 293* 52 20 101
CLOPIDOGREL 296 273 50 21 27
TAMSULOSIN HCL 293 272 50 22 26
ZOLPIDEM TARTRATE 287 239 62 23 28
METFORMIN HCL 274 251 52 24 13
GABAPENTIN 253 213 51 25 14
CARVEDILOL 238 213 45 26 21
ATENOLOL 235 230* 52 27 19
HYDROCODONE-ACETAMINOPHEN 232 171 64 S3 28 9
NEXIUM 229 174 46 29 46
LORAZEPAM 217 199 55 B 30 40
CELEBREX 209 204* 42 31 63
BYSTOLIC 206 195 37 32 54
OXYCODONE HCL 196 106 35 S2 33 107
ALENDRONATE SODIUM 191 151 28 34 29
DIOVAN 190 185* 34 35 42
VESICARE 186 181* 25 36 67
HYDROCHLOROTHIAZIDE 176 141 38 37 17
GLIMEPIRIDE 176 163 38 37 38
MELOXICAM 171 166* 39 39 32
QUETIAPINE FUMARATE 167 134 23 A 40 53
PANTOPRAZOLE SODIUM 156 131 30 41 25
FLUTICASONE PROPIONATE 152 130 64 42 35
MIRTAZAPINE 148 143* 26 43 47
TRIAMTERENE-HCTZ 147 147 29 44 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 142* 31 44 43
SPIRONOLACTONE 132 104 25 46 39
DONEPEZIL HCL 130 125* 21 47 30
NAMENDA 129 129 12 48 34
CALCITRIOL 122 109 20 49 201
BENAZEPRIL HCL 121 106 24 50 48
SYNTHROID 119 114* 25 51 41
LANTUS 118 97 21 52 60
CLONIDINE HCL 115 103 27 53 52
BENICAR 114 109* 24 54 92
ADVAIR DISKUS 109 92 27 55 51
CITALOPRAM HBR 109 81 19 55 20
TORSEMIDE 104 99* 33 57 89
AMITRIPTYLINE HCL 100 63 14 R 58 75
PIOGLITAZONE HCL 100 95* 15 R 58 86
LOSARTAN-HYDROCHLOROTHIAZIDE 95 90* 26 60 49
OXYCODONE-ACETAMINOPHEN 94 64 31 S2 61 87
FINASTERIDE 93 93 15 62 91
JANUVIA 93 80 19 62 84
LYRICA 92 80 20 64 82
CYCLOBENZAPRINE HCL 91 66 30 R 65 78
DILTIAZEM 24HR CD 91 86* 15 65 172
DIGOX 86 73 14 67 109
PAROXETINE HCL 86 69 14 67 73
PROPRANOLOL HCL 85 67 17 69 94
ESCITALOPRAM OXALATE 84 79* 16 70 36
FLUOXETINE HCL 83 52 17 71 85
MONTELUKAST SODIUM 83 78* 23 71 58
BD ULTRA-FINE PEN NEEDLE 82 65 20 73 126
CLONAZEPAM 80 62 16 B 74 55
LANTUS SOLOSTAR 78 61 15 75 71
LANSOPRAZOLE 76 71* 13 76 175
BENICAR HCT 76 57 11 76 158
HYDRALAZINE HCL 75 70* 16 78 114
MECLIZINE HCL 75 59 23 78 152
POLYETHYLENE GLYCOL 3350 74 69* 24 80 45
METHYLPREDNISOLONE 74 69* 48 80 153
AZITHROMYCIN 72 54 45 82 68
DILTIAZEM 24HR ER 69 69 14 83 147
ENALAPRIL MALEATE 69 69 13 83 65
CIPROFLOXACIN HCL 68 63* 53 85 56
SPIRIVA 67 46 13 86 69
CYMBALTA 64 59* 15 87 44
VERAPAMIL ER 64 51 11 87 142
PROAIR HFA 64 27 21 87 81
ISOSORBIDE MONONITRATE ER 62 57* 16 90 66
METFORMIN HCL ER 62 57* 12 90 62
TRAZODONE HCL 61 <11 <11 92 50
VALSARTAN-HYDROCHLOROTHIAZIDE 58 53* 15 93 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 53* 23 93 93
AMIODARONE HCL 58 58 13 93 111
FAMOTIDINE* 58 <11 <11 93 64
LOVASTATIN 56 <11 <11 97 71
WELCHOL 55 50* 14 98 128
ZETIA 54 <11 <11 99 70
LABETALOL HCL 54 <11 <11 99 177
DIAZEPAM 53 <11 <11 B 101 136
RAMIPRIL 53 <11 <11 101 79
RANITIDINE HCL 53 48* 12 101 57
HUMALOG 52 47* 14 104 123
IBANDRONATE SODIUM 51 <11 <11 105 226
LIDODERM 50 45* 18 106 156
LATANOPROST 50 45* 11 106 186
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.